Férid Haddad (F Haddad, Ferid Haddad)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Dalton transactions (Cambridge, England : 2003)

Pharmaceuticals (Basel, Switzerland)

Pharmaceutics

Cancers

GIP Arronax

Université de Nantes (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GIP Arronax Jul 01 2014

France

Director

Education History

Université de Nantes Sep 01 1991 - Oct 29 1993

France

PHD :: Physics

Publications

B Happl, Theresa Balber, Petra Heffeter, Christoph Denk, J M Welch, Ulli Koester, C Alliot, A-C Bonraisin, Marie R Brandt, Férid Haddad, Johannes H Sterba, Wolfgang Kandioller, M Mitterhauser, Marcus Hacker, Bernhard K Keppler, Thomas L Mindt
Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103. Dalton transactions (Cambridge, England : 2003) 53 (13) (2024)
B Happl, Theresa Balber, Petra Heffeter, Christoph Denk, J M Welch, Ulli Koester, C Alliot, A-C Bonraisin, Marie R Brandt, Férid Haddad, Johannes H Sterba, Wolfgang Kandioller, M Mitterhauser, Marcus Hacker, Bernhard K Keppler, Thomas L Mindt
Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103. Dalton transactions (Cambridge, England : 2003) 53 (13) (2024)
B Happl, Theresa Balber, Petra Heffeter, Christoph Denk, J M Welch, Ulli Koester, C Alliot, A-C Bonraisin, Marie R Brandt, Férid Haddad, Johannes H Sterba, Wolfgang Kandioller, M Mitterhauser, Marcus Hacker, Bernhard K Keppler, Thomas L Mindt
Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103. Dalton transactions (Cambridge, England : 2003) (2024)
Liliana Mou, Lucia De Dominicis, Sara Cisternino, Hanna Skliarova, Matteo Campostrini, Valentino Rigato, Laura De Nardo, Laura Melendez-Alafort, Juan Esposito, Férid Haddad, Gaia Pupillo
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48 Ti Targets for the Production of Theranostic 47 Sc Radionuclide, 46c Sc, 44m Sc, 44g Sc, 43 Sc, and 48 V. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Cassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, Catherine Chauvet, Séverine Marionneau-Lambot, Peter O Hofgaard, Bjarne Bogen, Julie Pineau, Nathalie Le Bris, Pr Raphael Tripier, Cyrille Alliot, Férid Haddad, Michel Cherel, Nicolas Chouin, Alain Faivre-Chauvet, Latifa Rbah-Vidal
Preclinical Evaluation of a 64 Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma. Pharmaceutics 15 (7) (2023)
Liliana Mou, Lucia De Dominicis, Sara Cisternino, Hanna Skliarova, Matteo Campostrini, Valentino Rigato, Laura De Nardo, Laura Melendez-Alafort, Juan Esposito, Férid Haddad, Gaia Pupillo
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48 Ti Targets for the Production of Theranostic 47 Sc Radionuclide, 46c Sc, 44m Sc, 44g Sc, 43 Sc, and 48 V. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Liliana Mou, Lucia De Dominicis, Sara Cisternino, Hanna Skliarova, Matteo Campostrini, Valentino Rigato, Laura De Nardo, Laura Melendez-Alafort, Juan Esposito, Férid Haddad, Gaia Pupillo
Nuclear Cross-Section of Proton-Induced Reactions on Enriched 48 Ti Targets for the Production of Theranostic 47 Sc Radionuclide, 46c Sc, 44m Sc, 44g Sc, 43 Sc, and 48 V. Pharmaceuticals (Basel, Switzerland) 17 (1) (2023)
Arthur Bongrand, Charbel Koumeir, Daphnée Villoing, Arnaud Guertin, Férid Haddad, Vincent Métivier, Freddy Poirier, Vincent Potiron, Noël Servagent, Stéphane Supiot, Grégory Delpon, Sophie Chiavassa
A Monte Carlo Determination of Dose and Range Uncertainties for Preclinical Studies with a Proton Beam. Cancers 13 (8) (2021)
Romain Eychenne, Michel Cherel, Férid Haddad, François Guérard, Jean-François Gestin
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight". Pharmaceutics 13 (6) (2021)
Clement Bailly, Sébastien Gouard, François Guérard, Benjamin Chalopin, Thomas Carlier, Alain Faivre-Chauvet, Patricia Remaud-Le Saëc, Mickaël Bourgeois, Nicolas Chouin, Latifa Rbah-Vidal, Pr Raphael Tripier, Férid Haddad, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Michel Chérel
What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model. International journal of molecular sciences 20 (10) (2019)

Férid Haddad.css-eqlu8i{font-size:small;padding-left:4px;} (F Haddad, Ferid Haddad)

Publication Activity (10 Years)

Top Topics

Top Venues

Férid Haddad (F Haddad, Ferid Haddad)